The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

Multiple FDA-approved SCS systems, such as Nevro’s Senza and HFX iQ, as well as Medtronic’s Vanta, Intellis, and Inceptiv systems are available, each offering different features to cater to individual ...

Dr. Greg Vigna Spinal cord stimulators are linked to over 80,000 injuries, with lead migration and hematomas causing severe harm <b ...

Medtronic plc’s MDT strength in the Cardiovascular ... the market is gaining from the continued launch of the Inceptiv closed-loop spinal cord stimulator. In brain stim, Percept RC with ...

Growth stocks have recently attracted investor interest. The Russell 3000 Growth Index returned 39.8% over the last year through Jan. 6. That was more than 24 percentage points better than the Russell ...

In pain stim, the market is gaining from the continued launch of the Inceptiv closed-loop spinal cord stimulator. In brain stim, Percept RC with BrainSense is registering strong sales. Gross Profit ...

and neuromodulation products (spinal cord stimulation. brain modulation that treats things like Parkinson's symptoms, and implantable drug infusions for chronic pain). Medtronic has several ...

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to ...